RecruitingNot ApplicableNCT06207994

PRICO: OPTI Target Range

Evaluation of the Impact of a Narrower SpO2 Target Range on Performance of an Automatic FiO2 Control System: a Randomized Study


Sponsor

Czech Technical University in Prague

Enrollment

10 participants

Start Date

Feb 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to determine if a narrower SpO2 Target Range setting automated control of FiO2 (A-FiO2) is more effective than a wider SpO2 Target Range


Eligibility

Min Age: 2 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Narrow TR and a medical device called Shifted TR for people with neonatal respiratory distress and very low birth weight infant. The study is currently recruiting participants at 1 location. People eligible for this study include aged 2 Weeks and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENarrow TR

The width of the PRICO SpO2 TR is set to 3% SpO2.

DEVICEShifted TR

The lower and the upper limits of the PRICO SpO2 TR are increased by 1% SpO2.


Locations(1)

Motol University Hospital

Prague, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06207994


Related Trials